A detailed history of Bank Of New Hampshire transactions in Pfizer Inc stock. As of the latest transaction made, Bank Of New Hampshire holds 1,266 shares of PFE stock, worth $34,764. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,266
Previous 2,181 41.95%
Holding current value
$34,764
Previous $61,000 40.98%
% of portfolio
0.01%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$27.7 - $31.39 $25,345 - $28,721
-915 Reduced 41.95%
1,266 $36,000
Q2 2024

Jul 01, 2024

SELL
$25.26 - $29.6 $107,102 - $125,504
-4,240 Reduced 66.03%
2,181 $61,000
Q1 2024

Apr 10, 2024

SELL
$25.89 - $29.73 $14,394 - $16,529
-556 Reduced 7.97%
6,421 $178,000
Q4 2023

Feb 02, 2024

SELL
$26.13 - $33.94 $138,070 - $179,338
-5,284 Reduced 43.1%
6,977 $200,000
Q3 2023

Oct 10, 2023

SELL
$32.09 - $37.51 $5,134 - $6,001
-160 Reduced 1.29%
12,261 $406,000
Q2 2023

Jul 28, 2023

SELL
$36.12 - $41.79 $65,377 - $75,639
-1,810 Reduced 12.72%
12,421 $455,000
Q1 2023

Apr 04, 2023

SELL
$39.39 - $51.28 $21,467 - $27,947
-545 Reduced 3.69%
14,231 $580,000
Q4 2022

Jan 10, 2023

SELL
$41.75 - $54.5 $55,318 - $72,212
-1,325 Reduced 8.23%
14,776 $757,000
Q3 2022

Oct 24, 2022

BUY
$43.76 - $53.42 $7,307 - $8,921
167 Added 1.05%
16,101 $705,000
Q2 2022

Jul 08, 2022

SELL
$46.53 - $55.17 $1,163 - $1,379
-25 Reduced 0.16%
15,934 $835,000
Q1 2022

Apr 20, 2022

BUY
$45.75 - $56.69 $8,463 - $10,487
185 Added 1.17%
15,959 $826,000
Q4 2021

Jan 12, 2022

SELL
$41.32 - $61.25 $95,738 - $141,916
-2,317 Reduced 12.81%
15,774 $931,000
Q2 2021

Jul 06, 2021

BUY
$35.91 - $40.68 $649,647 - $735,941
18,091 New
18,091 $708,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bank Of New Hampshire Portfolio

Follow Bank Of New Hampshire and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New Hampshire, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New Hampshire with notifications on news.